ru
Feedback
pace your MRCP-PACES

pace your MRCP-PACES

Открыть в Telegram

A platform for learning

Больше
2 521
Подписчики
-224 часа
-47 дней
-1430 день
Архив постов
27.Dr Ravi 26.Dr Priya 25.Dr Mujtaba Waris 24.Dr Shaheen Noman 23.Dr Apoorv Tiwari 22.Dr Niaz 21.Dr Janaki 20.Dr Lavanya Devi Palaniswamy 19.Dr Waqas 18.Dr Sadaf Hammad 17.Dr Osama Abdelaziz 16.Dr Rajeev Sharma 15.Dr Nehal Kunjomoidu 14.Dr Steffy 13.Dr Mustafizur Rahman (MRCPI) 12.Dr Vareeja Kasibian 11.Dr Niya Jamaludheen 10.Dr Farook Abdelgioum 9.Dr Kamran Ali 8.Dr Anik Rahman 7.Dr Manoj Dodiyah 6.Dr Madhusha 5.Dr Komal Zahid 4.Dr Hina Shaikh 3.Dr Sameer Abdus Samad 2.Dr Saurabh Gaba 1.Dr Rithik Mohan

paceUrMRCP-PACES HALL OF FAME We are thankful to our respected colleagues who have made us proud by their success in PACES MRCP ( UK ) and PART 2 CLINICAL EXAM MRCPI. We believe that this number will keep on increasing. 228.Dr Samson Charan 227.Dr Riyaz 226.Dr Geethika 225.Dr Adeyemo Abiodun Waliyullah 224.Dr Dipika 223.Dr Raihan 222.Dr Rafeea Shah 221.Dr Jason 220.Dr Ashiru Sikirat Yetunde 219.Dr Ghulam 218.Dr Mehwish Usman 217.Dr Lau Wen Jie 216.Dr H.Kumara 215.Dr Darshini 214.Dr Geetha 213.Dr seema 212.Dr Akheri Parvin 211.Dr Syed Najam Al Hassan Shah 210.Dr Umair 209.Dr Rakhwin Sandhu 208. Dr Raymond Madzivanyika 207.Dr Nabeel 206.Dr Sidra Aslam 205.Dr Narendra 204.Dr Rashmy Arun 203.Dr Sandhya 202.Dr Narayanee Rajasekaran 201.Dr Ismail Fawaz 200.Dr Daphnie 199.Dr Stephen Ponnampalam 198.Dr Mohammed Ahmed 197.Dr Yasmin Yusuf 196.Dr Praveetha 195.Dr Sarthak Rastogi 194.Dr Ahammed Ashar 193.Dr Mohamed Abdullahi 192.Dr Sankar Nath Jha 191.Dr Asim 190.Dr Chia 189.Dr Md Kabir Udin 188.Dr Khai Leng 187.Dr Shaima Bashir 186.Dr Joel Quadros 185.Dr Suroop Chand 184.Dr Mayesha 183.Dr Poornima Nair 182.Dr Munira 181.Dr Maryam Abdalla 180.Dr Kokila 179.Dr Thushani 178.Dr Irfan Ahmad Mir 174.Dr Mohammed Abubaker 173.Dr Asrul 172.Dr Toqeer Bhatti 171.Dr Elanchezian 170.Dr Muthumani 169.Dr Muhammad Idrees 168.Dr Tan Wei Loon 167.Dr Muhammad Afkham ( MRCPI ) 166.Dr Ismail Fawaz ( MRCPI ) 165.Dr Javeria 164.Dr Adan 163.Dr Aisha 162.Dr Mehwish Touseef 161.Dr Mahabalraj 160.Dr Gouri. 159.Dr Nicholas 158.Dr Sashank Chavali 157.Dr Charles Chun 156.Dr Johnny Khor 155. Dr G Karthikeyan 154.Dr Irshad Khan 153.Dr Umamah 152.Dr Ammara Ansar 151.Dr Tasnuva Aman Khan 150.Dr Mohammed Akif Bin Haleem 149.Dr Adil Tahseen 148.Dr Meera Patil 147.Dr Ashini ( MRCPI ) 146.Dr Ali Moùsa ( MRCPI ) 145.Dr Naomi ( MRCPI ) 144.Dr Samreen Mazhar 143.Dr Sairam 142.Dr Priya 141.Dr Yousuf 140.Dr Moe Pwint Phyu 139.Dr Fahad Ul Fazal 138.Dr Ravi Bangeja 137.Dr Vamshidhar Vanam 136.Dr Hanadi ( MRCPI ) 135.Dr Azher ( MRCPI ) 134.Dr Noman Hossain 133.Dr Abhinav Meelu 132.Dr Nurul Islam 131.Dr kadhaum ibrahem 130.Dr Inayut 129.Dr Susovan Mitra 128.Dr Bhavesh Kaswala 127.Dr Rashid Ali Khan 126.Dr Bisma 125.Dr Samiah 124.Dr Madiha Mahmood 123.Dr Ratan Kumar 122.Dr Dilfuza Usmanova 121.Dr Mohd Hafiz 120.Dr Colin Cheah 119.Dr Kuan Yau Yeh 118.Dr Satesh Ramasundram 117.Dr Calvin 116.Dr Wan Mohamad 115.Dr Aravinthan Balakrishnan 114.Dr Athirah Azizol 113.Dr Massum 112.Dr Rafa Faaria Alam 111.Dr Benojeer Akter 110.Dr Sonal Karpe 109.Dr Shahla 108.Dr Muhammad Faizal 107.Dr Aisha Sohail 106.Dr Sheetal 105.Dr Anand Kumar 104.Dr Paul 103.Dr Ehsan Ul Haq 102.Dr Amna Gardezi 101.Dr Muhammad Rahib 100.Dr Shilpa 99.Dr Nagaraj Patil 98.Dr Vincent Jose ( MRCPI ) 97.Dr Hana Abdalla Adam Mohamed ( MRCPI ) 96.Dr Thanuja Alahakoon 95.Dr Farehah ( MRCPI ) 94.Dr Sankar Nath Jha ( MRCPI ) 93.Dr Saadia Khan 92.Dr Montasir Elmobark 91.Dr Kiran 90.Dr Ai Yun Loh 89.Dr Eow 88.Dr Lim 87.Dr Lalitha 86.Dr Ashwin Mathew 85.Dr Kasthuri 84.Dr Rohit 83.Dr Sangshaptak Saha 82.Dr Hira Jamil 81.Dr Santa Subhra Chatterjee 80.Dr Shishir 79.Dr Rubeya Ahmad 78.Dr Javaria Imran 77.Dr Rishi Gopalakrishnan 76.Dr Ramandeep Kaur 75.Dr Shakeel 74.Dr Shamla 73.Dr Murtaza 72.Dr Urvashi 71.Dr Urmimala Bhattacharjee 70.Dr Jayalakshmi 69.Dr Steffin Methai Kattor 68.Dr Yew 67.Dr Cyrin 66.Dr Farhat Nazneen 65.Dr Meenal 64.Dr Adil 63.Dr Umar Iftikhar 62.Dr Sohail ( MRCPI ) 61.Dr Amarnath duraikannan 60.Dr Maha 59.Dr Samar 58.Dr Sidra German 57.Dr Mahmood Akhtar 56.Dr Muhammad Hashim 55.Dr Manmohan 54.Dr Pooja 53.Dr Haithem Alghebra ( MRCPI ) 52.Dr Amna 51.Dr Nandhakumar 50.Dr Ew Ju Vern 49.Dr Mohamed Muslim 48.Dr Jerry John 47.Dr Majid Iqbal 46.Dr Phoebe 45.Dr Aimi N Zainudin 44.Dr Tahseen Azim 43.Dr Samina 42.Dr Suzi 41.Dr Samia 40.Dr Tan 39.Dr Kalpesh Kondalkar 38.Dr Sunil Abhishek 37.Dr Faiz Mashood ( MRCPI ) 36.Dr Sharalaa Engatramana 35.Dr Prasad ( MRCPI ) 34.Dr Kalyan Nath ( MRCPI ) 33.Dr Reshma Thalikan 32.Dr Aneesa Shahul 31.Dr Arooj 30.Dr Esraa Soliman 29.Dr Amitave Chatterjee 28.Dr Malik Dilaver

👉 *IMPORTANT 623* 👈 *A brief introduction of Hodgkin Lymphoma* Hodgkin’s lymphoma is a rare haematological malignancy (accounts for<1% of all cancers in the UK) caused by the uncontrolled proliferation of B-lymphocytes. These cells travel through the lymphatic system and build up in the lymph nodes causing lymphadenopathy. They can also spread to other organs such as the spleen or bone marrow. Hodgkin’s lymphoma is differentiated from non-Hodgkin’s lymphoma based on its histological appearance of huge multinucleated lymphocytes called Reed-Sternberg cells. Chemotherapy +/- radiotherapy are the main treatments of Hodgkin's lymphoma, and overall patients have a good prognosis with a 5-year survival rate of 80-90% in the early stages and 40-80% in the advanced stages. paceUrMRCP.

👉 *IMPORTANT 622* 👈 *Few conditions associated with a positive RF* Other conditions associated with a positive RF include Sjogren's syndrome (around 100%) Felty's syndrome (around 100%) infective endocarditis (= 50%) SLE (= 20-30%) systemic sclerosis (= 30%) general population (= 5%) rarely: TB, HBV, EBV, leprosy paceUrMRCP.

👉 *IMPORTANT 621* 👈 *Few extraocular complications of rheumatoid arthritis (RA)* A wide variety of extra-articular complications occur in patients with rheumatoid arthritis (RA): respiratory: pulmonary fibrosis, pleural effusion, pulmonary nodules, bronchiolitis obliterans, methotrexate pneumonitis, pleurisy ocular: keratoconjunctivitis sicca (most common), episcleritis, scleritis, corneal ulceration, keratitis, steroid-induced cataracts, chloroquine retinopathy osteoporosis ischaemic heart disease: RA carries a similar risk to type 2 diabetes mellitus increased risk of infections depression Less common Felty's syndrome (RA + splenomegaly + low white cell count) amyloidosis paceUrMRCP.

ANNOUNCEMENT FOR ONLINE COURSE NO 41 ( 24 June 24—12 July 24 ) Hello and salam everyone. We are pleased to announce admissions for our July 2024 online course ( 15 days ) for PACES MRCP (UK) and CLINICAL EXAM MRCPI . We will start from 24th of June 24 and finish on 12th of July 24. Active slots available on first come--first served basis. Listener slot available too. At least 90 Important exam cases ( including recent diets cases ) will be practiced and discussed as we do in our weekly Sunday sessions. After the performance detailed feedback will be given to elaborate the weak skills. It is equally beneficial for those who are beginners or have exams in coming diet. Interested candidates may send a personal message for details. WhatsApp No: +923346036496. Email: drtanzeelbukhari@gmail.com GOOD LUCK.

Dear colleagues We will start our academic activities tomorrow. Thanks for your patience. Regards.

ANNOUNCEMENT FOR ONLINE COURSE NO 41 ( 24 June 24—12 July 24 ) Hello and salam everyone. We are pleased to announce admissions for our July 2024 online course ( 15 days ) for PACES MRCP (UK) and CLINICAL EXAM MRCPI . We will start from 24th of June 24 and finish on 12th of July 24. Active slots available on first come--first served basis. Listener slot available too. At least 90 Important exam cases ( including recent diets cases ) will be practiced and discussed as we do in our weekly Sunday sessions. After the performance detailed feedback will be given to elaborate the weak skills. It is equally beneficial for those who are beginners or have exams in coming diet. Interested candidates may send a personal message for details. WhatsApp No: +923346036496. Email: drtanzeelbukhari@gmail.com GOOD LUCK.

ANNOUNCEMENT FOR ONLINE COURSE NO 41 ( 24 June 24—12 July 24 ) Hello and salam everyone. We are pleased to announce admissions for our July 2024 online course ( 15 days ) for PACES MRCP (UK) and CLINICAL EXAM MRCPI . We will start from 24th of June 24 and finish on 12th of July 24. Active slots available on first come--first served basis. Listener slot available too. At least 90 Important exam cases ( including recent diets cases ) will be practiced and discussed as we do in our weekly Sunday sessions. After the performance detailed feedback will be given to elaborate the weak skills. It is equally beneficial for those who are beginners or have exams in coming diet. Interested candidates may send a personal message for details. WhatsApp No: +923346036496. Email: drtanzeelbukhari@gmail.com GOOD LUCK.

ANNOUNCEMENT FOR ONLINE COURSE NO 41 ( 24 June 24—12 July 24 ) Hello and salam everyone. We are pleased to announce admissions for our July 2024 online course ( 15 days ) for PACES MRCP (UK) and CLINICAL EXAM MRCPI . We will start from 24th of June 24 and finish on 12th of July 24. Active slots available on first come--first served basis. Listener slot available too. At least 90 Important exam cases ( including recent diets cases ) will be practiced and discussed as we do in our weekly Sunday sessions. After the performance detailed feedback will be given to elaborate the weak skills. It is equally beneficial for those who are beginners or have exams in coming diet. Interested candidates may send a personal message for details. WhatsApp No: +923346036496. Email: drtanzeelbukhari@gmail.com GOOD LUCK.

Eid Mubarak dear colleagues, please excuse me for Eid Holidays, we will start again after eid, regards and good luck

ANNOUNCEMENT FOR ONLINE COURSE NO 41 ( 24 June 24—12 July 24 ) Hello and salam everyone. We are pleased to announce admissions for our July 2024 online course ( 15 days ) for PACES MRCP (UK) and CLINICAL EXAM MRCPI . We will start from 24th of June 24 and finish on 12th of July 24. Active slots available on first come--first served basis. Listener slot available too. At least 90 Important exam cases ( including recent diets cases ) will be practiced and discussed as we do in our weekly Sunday sessions. After the performance detailed feedback will be given to elaborate the weak skills. It is equally beneficial for those who are beginners or have exams in coming diet. Interested candidates may send a personal message for details. WhatsApp No: +923346036496. Email: drtanzeelbukhari@gmail.com GOOD LUCK.

please join

870936

Announcement for Online Session No 120 16 June 2024 DEAR DOCTORS : MAY I HAVE YOUR ATTENTION PLEASE: Today we will have an online session on Zoom discussing 1 Long Clinical Consultation Station regarding our preparation for MRCP PACES ( UK ) and MRCPI ( Ireland ) WE WILL NOT RECORD THIS SESSION The candidate for today's session has been selected. TIMINGS : Saudia Arabia: 4 00 pm Pakistan : 6 00 pm Bangladesh : 7 00 pm India : 6 30 pm Singapore : 9 00 pm Hong Kong : 9 00 pm Malaysia : 9 00 pm Egypt : 3 00 pm Libya : 3 00 pm Bahrain : 4 00 pm Burma ( Myanmar ) :7 30 pm Sudan : 3 00 pm UAE : 5 00 pm UK : 2 00 pm Ireland ( Dublin ) : 2 00 pm Afghanistan : 5 30 pm Kenya : 4 00 pm Germany ( Berlin ) : 3 00 pm Nigeria : 2 00 pm Japan ( Tokyo ) : 10 00 pm Denmark : 3 00 pm Qatar : 4 00 pm Oman : 5 00 pm Italy : 3 00 pm Indonesia : 8 00 pm Mauritius : 5 00 pm Iraq : 4 00 pm Texas Usa : 8 00 am Kuwait : 4 00 pm Sri Lanka : 6 30 pm Somalia : 4 00 pm Zimbabwe : 3 00 pm China ( Beijing ) : 9 00 pm Australia ( Sydney) : 11 00 pm Burundi : 3 00 pm Rwanda : 3 00 pm Morocco : 1 00 pm French Guiana : 10 00 am ( Please Google for your local time zones to avoid any inconvenience ) Zoom meeting link will be shared 5 minutes before start time. GOOD LUCK.

ANNOUNCEMENT FOR ONLINE COURSE NO 41 ( 24 June 24—12 July 24 ) Hello and salam everyone. We are pleased to announce admissions for our July 2024 online course ( 15 days ) for PACES MRCP (UK) and CLINICAL EXAM MRCPI . We will start from 24th of June 24 and finish on 12th of July 24. Active slots available on first come--first served basis. Listener slot available too. At least 90 Important exam cases ( including recent diets cases ) will be practiced and discussed as we do in our weekly Sunday sessions. After the performance detailed feedback will be given to elaborate the weak skills. It is equally beneficial for those who are beginners or have exams in coming diet. Interested candidates may send a personal message for details. WhatsApp No: +923346036496. Email: drtanzeelbukhari@gmail.com GOOD LUCK.

Announcement for Online Session No 120 16 June 2024 DEAR DOCTORS : MAY I HAVE YOUR ATTENTION PLEASE: Tomorrow we will have an online session on Zoom discussing 1 Long Clinical Consultation Station regarding our preparation for MRCP PACES ( UK ) and MRCPI ( Ireland ) WE WILL NOT RECORD THIS SESSION Interested candidate may send a personal message to take the case. TIMINGS : Saudia Arabia: 4 00 pm Pakistan : 6 00 pm Bangladesh : 7 00 pm India : 6 30 pm Singapore : 9 00 pm Hong Kong : 9 00 pm Malaysia : 9 00 pm Egypt : 3 00 pm Libya : 3 00 pm Bahrain : 4 00 pm Burma ( Myanmar ) :7 30 pm Sudan : 3 00 pm UAE : 5 00 pm UK : 2 00 pm Ireland ( Dublin ) : 2 00 pm Afghanistan : 5 30 pm Kenya : 4 00 pm Germany ( Berlin ) : 3 00 pm Nigeria : 2 00 pm Japan ( Tokyo ) : 10 00 pm Denmark : 3 00 pm Qatar : 4 00 pm Oman : 5 00 pm Italy : 3 00 pm Indonesia : 8 00 pm Mauritius : 5 00 pm Iraq : 4 00 pm Texas Usa : 8 00 am Kuwait : 4 00 pm Sri Lanka : 6 30 pm Somalia : 4 00 pm Zimbabwe : 3 00 pm China ( Beijing ) : 9 00 pm Australia ( Sydney) : 11 00 pm Burundi : 3 00 pm Rwanda : 3 00 pm Morocco : 1 00 pm French Guiana : 10 00 am ( Please Google for your local time zones to avoid any inconvenience ) Zoom meeting link will be shared 5 minutes before start time. GOOD LUCK.

ANNOUNCEMENT FOR ONLINE COURSE NO 41 ( 24 June 24—12 July 24 ) Hello and salam everyone. We are pleased to announce admissions for our July 2024 online course ( 15 days ) for PACES MRCP (UK) and CLINICAL EXAM MRCPI . We will start from 24th of June 24 and finish on 12th of July 24. Active slots available on first come--first served basis. Listener slot available too. At least 90 Important exam cases ( including recent diets cases ) will be practiced and discussed as we do in our weekly Sunday sessions. After the performance detailed feedback will be given to elaborate the weak skills. It is equally beneficial for those who are beginners or have exams in coming diet. Interested candidates may send a personal message for details. WhatsApp No: +923346036496. Email: drtanzeelbukhari@gmail.com GOOD LUCK.

👉 *IMPORTANT 620* 👈 *The management of rheumatoid arthritis (RA)* The management of rheumatoid arthritis (RA) has been revolutionised by the introduction of disease-modifying therapies in the past decade. Patients with evidence of joint inflammation should start a combination of disease-modifying drugs (DMARD) as soon as possible. Other important treatment options include analgesia, physiotherapy and surgery. *Initial therapy* In 2018 NICE updated their rheumatoid arthritis guidelines. They now recommend DMARD monotherapy +/- a short-course of bridging prednisolone. In the past dual DMARD therapy was advocated as the initial step. *Monitoring response to treatment* NICE recommends using a combination of CRP and disease activity (using a composite score such as DAS28) to assess response to treatment *DMARDs* methotrexate is the most widely used DMARD. Monitoring of FBC & LFTs is essential due to the risk of myelosuppression and liver cirrhosis. Other important side-effects include pneumonitis sulfasalazine leflunomide hydroxychloroquine *TNF-inhibitors* the current indication for a TNF-inhibitor is an inadequate response to at least two DMARDs including methotrexate etanercept: recombinant human protein, acts as a decoy receptor for TNF-α, subcutaneous administration, can cause demyelination, risks include reactivation of tuberculosis infliximab: monoclonal antibody, binds to TNF-α and prevents it from binding with TNF receptors, intravenous administration, risks include reactivation of tuberculosis adalimumab: monoclonal antibody, subcutaneous administration *Rituximab* anti-CD20 monoclonal antibody, results in B-cell depletion two 1g intravenous infusions are given two weeks apart infusion reactions are common *Abatacept* fusion protein that modulates a key signal required for activation of T lymphocytes leads to decreased T-cell proliferation and cytokine production given as an infusion not currently recommend by NICE paceUrMRCP.